LSA
INBX

Leonteq Securities AG’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Leonteq Securities AG’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-360
Closed -$8.02K – 1367
2022
Q1 		$8.02K Hold
360
– – ﹤0.01% 1136
2021
Q4 		$15.7K Buy
+360
New +$14.4K ﹤0.01% 1099

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Leonteq Securities AG's INBX Position: Q2 2022 in Review

Leonteq Securities AG sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2022, closing a stake of 360 shares — an estimated $8.02K sold.

Leonteq Securities AG first reported a position in INBX in Q4 2021 and held it in 2 quarters. The position peaked at $15.7K in Q4 2021. 100 funds tracked by Wall St. Rank hold INBX as of Q2 2022.

  • Leonteq Securities AG reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Leonteq Securities AG sold 360 Inhibrx, Inc. Common Stock shares in Q2 2022, an estimated $8.02K.
  • Leonteq Securities AG first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Leonteq Securities AG's Inhibrx, Inc. Common Stock position peaked at $15.7K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2022.

Based on Leonteq Securities AG's 13F filing for Q2 2022, filed 26 Mar 2026.